Torrent Pharmaceuticals Ltd.
| BSE: 500420 | Sector: Health care |
| NSE: TORNTPHARM | ISIN Code: INE685A01028 |
| BSE 10:00 | 29 Jun | 2862.00 |
-20.15 (-0.70%) |
OPEN
2870.25 |
HIGH
2903.90 |
LOW
2861.95 |
| NSE 09:44 | 29 Jun | 2858.10 |
-25.65 (-0.89%) |
OPEN
2869.00 |
HIGH
2907.65 |
LOW
2855.00 |
| OPEN | 2870.25 |
| PREVIOUS CLOSE | 2882.15 |
| VOLUME | 418 |
| 52-Week high | 3304.45 |
| 52-Week low | 2485.00 |
| P/E | 48.87 |
| Mkt Cap.(Rs cr) | 48,431 |
| Buy Price | 2857.55 |
| Buy Qty | 10.00 |
| Sell Price | 2861.90 |
| Sell Qty | 8.00 |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 517.90 | -3.40 | -0.65 | 3112.91 |
| Cipla | 931.10 | -13.60 | -1.44 | 2468.28 |
| Dr Reddy's Labs | 4380.00 | 5.35 | 0.12 | 2186.40 |
| Sun Pharma.Inds. | 828.35 | 0.40 | 0.05 | 2139.70 |
| Divi's Lab. | 3563.00 | -50.95 | -1.41 | 1954.72 |
| Alkem Lab | 2964.85 | -25.45 | -0.85 | 1685.08 |
| Glenmark Pharma. | 384.95 | -2.50 | -0.65 | 1649.45 |
| Zydus Lifesci. | 356.20 | -1.55 | -0.43 | 1476.20 |
| Lupin | 628.80 | -4.75 | -0.75 | 1258.62 |
| Alembic Pharma | 732.60 | -5.65 | -0.77 | 1175.39 |
| Ipca Labs. | 895.80 | -6.40 | -0.71 | 1140.77 |
| Torrent Pharma. | 2862.00 | -20.15 | -0.70 | 1137.85 |
| Gland Pharma | 2696.35 | 48.70 | 1.84 | 997.01 |
| Sanofi India | 6453.10 | 46.95 | 0.73 | 944.40 |
| Laurus Labs | 465.95 | -2.75 | -0.59 | 750.09 |
| Abbott India | 18166.10 | 40.00 | 0.22 | 690.69 |
| Ajanta Pharma | 1246.40 | 5.50 | 0.44 | 675.64 |
| Wockhardt | 213.75 | 1.05 | 0.49 | 593.29 |
| Granules India | 275.95 | 0.55 | 0.20 | 552.78 |
| Pfizer | 4090.00 | -8.30 | -0.20 | 497.61 |
Quick Links for Torrent Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
